Earlier studies have reported that LYZ, PIP, and LCN1 are downregulated in AD (Kenny et al. 2019; Kalló et al. 2016) and lacrimal gland dysfunction has been suggested, which may be the reason for the observed reduced expression in our study (Kalló et al. 2016). Here, LYZ is linked to Alzheimer disease.